Insider Buying: Renalytix Plc (LON:RENX) Insider Acquires 53,300 Shares of Stock

Renalytix Plc (LON:RENX) insider James Renwick McCullough bought 53,300 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were purchased at an average cost of GBX 8 ($0.10) per share, with a total value of £4,264 ($5,433.92).

Renalytix Stock Performance

RENX opened at GBX 7.93 ($0.10) on Monday. The firm has a 50 day moving average of GBX 7.71 and a two-hundred day moving average of GBX 11.53. The firm has a market capitalization of £13.15 million, a PE ratio of -33.02 and a beta of 2.10. The company has a current ratio of 0.53, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95. Renalytix Plc has a 12-month low of GBX 6.50 ($0.08) and a 12-month high of GBX 74.90 ($0.95).

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.